In this volume, we explore various pharmacologic treatments in pediatric psychiatry. We begin with a study on escitalopram’s approval for treating children’s anxiety disorder and vortioxetine’s impact on sleep patterns in adolescents with major depressive disorder (MDD). We also consider the potential of long-acting injectable aripiprazole lauroxil as a safe treatment option for hospitalized teenagers with illnesses like schizophrenia. Lastly, we examine esketamine s effect on cognitive function in adolescents with MDD and suicidal ideation and assess risperidone’s efficacy in treating anorexia nervosa, which unfortunately showed no significant outcome differences.
- Provider:Medical Academy, LLC
- Activity Link: https://psychopharmacologyinstitute.com/publication/cap-smart-takes-vol-18-2782?utm_source=PARS+ACCME&utm_medium=PARS+ACCME&utm_campaign=PARS+ACCME
- Start Date: 2024-02-01 06:00:00
- End Date: 2024-02-01 06:00:00
- Credit Details: AMA PRA Category 1 Credit™️: 0.5 hours
- Commercial Support: No
- Activity Type: Enduring Material
- CME Finder Type: Online Learning
- Fee to Participate: Yes
- Measured Outcome: Learner Performance
- Provider Ship: Jointly Provided
- Registration: Limited
Subscribe
Login
0 Comments
Oldest